Eupraxia Pharmaceuticals (EPRX) Dividends Paid - Common (2023 - 2025)
Eupraxia Pharmaceuticals' (EPRX) quarterly Dividends Paid - Common came in at $69.2 million in Q3 2025, up 572.17% year-on-year from $10.3 million in Q3 2024, and up 999.91% on a QoQ basis from -$7.7 million in Q2 2025.
Eupraxia Pharmaceuticals (EPRX) Dividends Paid - Common (2023 - 2025) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has 3 years of Dividends Paid - Common data on file, last reported at $69.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Eupraxia Pharmaceuticals | 357.29 Mn | 355.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 69.19 Mn |
| Sep 30, 2025 | 69.19 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Jun 30, 2025 | -7.69 Mn |
| Mar 31, 2025 | 27.45 Mn |
| Mar 31, 2025 | 27.45 Mn |
| Sep 30, 2024 | -14.65 Mn |
| Sep 30, 2024 | -14.65 Mn |
| Jun 30, 2024 | -12.59 Mn |
| Jun 30, 2024 | -12.59 Mn |
| Mar 31, 2024 | 35.91 Mn |
| Mar 31, 2024 | 35.91 Mn |
| Sep 30, 2023 | 10.14 Mn |
| Sep 30, 2023 | 10.14 Mn |
| Jun 30, 2023 | 495,057.00 |
| Jun 30, 2023 | 495,057.00 |
| Mar 31, 2023 | 13.93 Mn |
| Mar 31, 2023 | 13.93 Mn |